Clinical assessment of the efficacy of anticancer treatment: Current status and perspectives

Chinese Journal of Cancer

Volumn 29, Issue 2, 2010, Pages 234-238

  Zhang, Jing Jing ^a   Meng, Qiong ^a   Chang, Wei ^a   Wan, Chong Hua ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Clinical assessment; Modern medicine; Review; Traditional chinese medicine; Tumor

Indexed keywords

ANALGESIC AGENT; GEMCITABINE;

CANCER PAIN; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CHINESE MEDICINE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; DISTANT METASTASIS FREE SURVIVAL; DRUG DOSE REDUCTION; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PANCREAS CANCER; PROGNOSIS; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RELAPSE FREE SURVIVAL; REVIEW; SOLID TUMOR; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; TIME OF TUMOR PROGRESSION; TREATMENT RESPONSE;

EID: 79955802747     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10598     Document Type: Review

References (33)

1. World Health Organization. WHO handbook for reporting results of cancer treatment [M]. Geneva (Switzerland): World Health Organization, 1979.
2. Sun Y. Medical Oncology [M]. Beijing: People's Medical Publication House, 2001:1994. [in Chinese].
3. Zhou JC. Practice of Medical Oncology [M]. Beijing: People's Medical Publication House, 1999:34,484 [in Chinese].
4. Robertson JF, Willsher PC, Cheung KL, et al. The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer [J]. Eur J Cancer, 1997,33(11):1774-1779.
5. Chen ZF, Li CZ. Meta analysis on primary non-small cell lung carcinoma (NSCLC) treated by TCM in China [J]. J Traditional Chin Med, 1999,40 (5):287-289. [in Chinese]
6. Duffaud F, Therasse P. New guidelines to evaluate the response to treatment in solid tumors [J]. Bull Cancer, 2000,87(12):869-870.
7. James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement [J]. J Natl Cancer Inst, 1999,91(6):523-528.
8. Gong Tian Jia Dian. A guide to Response Evaluation Criteria in Solid Tumors: digestive tract carcinomas [J]. Progress Jpn Med, 2001,22(11):486-488 [in Chinese]
9. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) [J]. Eur J Cancer, 2009,45(2):228-247.
10. Schwartz LH, Bogaerts J, Ford R, et al. Evaluation of lymph nodes with RECIST 1.1 [J]. Eur J Cancer, 2009,45(2):261-267.
11. Lin LZ, Lan SQ, Zhou DH. A Discussion on the Criterion of Therapeutical Effect of Malignant Tumor (solid carcinoma in TCM [J]. New J Traditional Chin Med, 2001,33(8):5. [in Chinese]
12. Chu DT. Integration of Traditional Chinese Medicine and Western Medicine in Response Evaluation Criteria [J]. Chin Prescription Drug, 2004,29(8): 42-45. [in Chinese]
13. Schipper H, Clinch J, McMurray A, et al. Measuring the quality of life in cancer patients. The Functional Living Index-cancer: development and validation [J]. J Clin Oncol, 1984,2(5):472-483.
14. FDA. Guidance for industry-patient-reported outcome measures: use in medical product development to support labeling claims, draft guidance [J]. Health Qual Life Outcomes, 2006,4:79.
15. Aaronson NK, Meyerowitz BE, Bard M, et al. Quality of life research in oncology. Past achievement and future priorities [J]. Cancer, 1991,67(3 Suppl):839-843.
16. Lane DA. Utility decision and quality of life [J]. J Chronic Dis, 1987,40(6): 585-591.
17. Lin HS, Li DR. Quality of life and assessment on tumor therapeutic effect of traditional Chinese medicine [J]. Oncol Progress, 2007,5 (3):249-251. [in Chinese].
18. Yao Y. Discussion of validity of quality of life in clinical effect assessment of malignant tumor treated with traditional Chinese medicine [J]. J Shanxi Coll Traditional Chin Med, 2008,31(1):13-14. [in Chinese].
19. Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: a randomized trial [J]. J Clin Oncol, 1997,15(6):2403-2413.
20. O'Shaughnessy JA, Wittes RE, Burke G, et al. Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in [29] clinical trials [J]. J Clin Oncol, 1991, 9(12):2225-2232.
21. Wang ST, Zhou DH. Comment on the current evaluation standard of the clinical curative effect of malignant tumor [J]. Tianjin J Traditional Chin Med, 2004,21(4):277-280. [in Chinese].
22. Zhang TZ, Xu GW. Oncology [M]. Tianjin: Tianjin Sci-Tech Press, 1996: 830. [in Chinese].
23. King DM. The radiology of gastrointestinal stromal tumours (GIST) [J]. Cancer Imaging, 2005,5:150-156.
24. Luo RC, Yao GY. Advances in molecular targeted therapy and biochemotherapy in oncology [J]. Chin J Cancer Biother, 2009,16(2):101-105. [in Chinese].
25. Zhou DH. Clinical Oncology in Traditional Chinese Medicine [M]. Beijing: People's Medical Publication House, 2003:620-622. [in Chinese].
26. Xue AZ, Lin LZ. Application of response evaluation criteria of traditional Chinese medicine for solid tumor in late non-small-cell lung cancer [J]. J Guangzhou Univ Traditional Chin Med, 2009,26(2):108-112. [in Chinese].
27. Liu BY, Li HJ, He LY, et al. The progress of assessment of syndrome in traditional Chinese medicine[J]. J Traditional Chin Med, 2009,50(5):397-421. [in Chinese].
28. Chen JX, Zhai D. Progress on the quantitative diagnostic methods in TCM [J].China J Traditional Chin Med Pharm, 1999,14(6):63-66. [in Chinese].
29. Yang YF, Zhu YW, Wu Y, et al. Discussion and preliminary application on standard for comprehensive efficacy assessment of traditional Chinese medicine in treating malignant tumor [J]. Chin J Integr Traditional Western Med, 1999,19(6):340-343. [in Chinese].
30. Shi ZM, Tian JH. Correlative factors for cancer response evaluation treated by TCM [J]. Shanghai J Traditional Chin Med, 2006,40(10):16-18. [in Chinese].
31. Wang JM, Li PW, Hou J, et al. Discussion of assessment of tumor treated by TCM [J]. Traditional Chin Med Res, 1994,7(3):44-45. [in Chinese].
32. Que HF, Chen HF, Xu JN, et al. Discussion of relationship between quality of life and clinical effect assessment of malignant tumor treated with traditional Chinese medicine [J]. J Chin Integrative Med, 2005,3(4):253-256. [in Chinese].
33. Li Z, Chen XY, Liu D. Therapeutic method of lung cancer treated with TCM in China [J]. J Basic Med Traditional Chin Med, 2005,11 (2):149-150. [in Chinese].